541 related articles for article (PubMed ID: 30241395)
21. IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma.
Qiao Y; Zhang C; Li A; Wang D; Luo Z; Ping Y; Zhou B; Liu S; Li H; Yue D; Zhang Z; Chen X; Shen Z; Lian J; Li Y; Wang S; Li F; Huang L; Wang L; Zhang B; Yu J; Qin Z; Zhang Y
Oncogene; 2018 Feb; 37(7):873-883. PubMed ID: 29059160
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of ECM-induced dormancy and chemoresistance in A549 human lung carcinoma cells.
Keeratichamroen S; Lirdprapamongkol K; Svasti J
Oncol Rep; 2018 Apr; 39(4):1765-1774. PubMed ID: 29436672
[TBL] [Abstract][Full Text] [Related]
23. Aurora kinase inhibitor VX-680 enhances sensitivity of esophageal squamous cell carcinoma cells to cisplatin chemotherapy.
Kou J; Wang X; Wei Y; Zhao R; Wang X; He J; Li X; Wang X
Anticancer Drugs; 2021 Oct; 32(9):969-977. PubMed ID: 34016831
[TBL] [Abstract][Full Text] [Related]
24. Chemoresistance to Cancer Treatment: Benzo-α-Pyrene as Friend or Foe?
Dzobo K; Hassen N; Senthebane DA; Thomford NE; Rowe A; Shipanga H; Wonkam A; Parker MI; Mowla S; Dandara C
Molecules; 2018 Apr; 23(4):. PubMed ID: 29673198
[No Abstract] [Full Text] [Related]
25. Adiponectin Is Involved in Connective Tissue Growth Factor-Induced Proliferation, Migration and Overproduction of the Extracellular Matrix in Keloid Fibroblasts.
Luo L; Li J; Liu H; Jian X; Zou Q; Zhao Q; Le Q; Chen H; Gao X; He C
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28498357
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
[TBL] [Abstract][Full Text] [Related]
27. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.
Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY
Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009
[TBL] [Abstract][Full Text] [Related]
28. Mitogen-activated protein kinase signaling causes malignant melanoma cells to differentially alter extracellular matrix biosynthesis to promote cell survival.
Afasizheva A; Devine A; Tillman H; Fung KL; Vieira WD; Blehm BH; Kotobuki Y; Busby B; Chen EI; Tanner K
BMC Cancer; 2016 Mar; 16():186. PubMed ID: 26944546
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of DDX46 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma cells.
Li B; Li YM; He WT; Chen H; Zhu HW; Liu T; Zhang JH; Song TN; Zhou YL
Oncol Rep; 2016 Jul; 36(1):223-30. PubMed ID: 27176873
[TBL] [Abstract][Full Text] [Related]
30. Multiple Signal Pathways Involved in Crocetin-Induced Apoptosis in KYSE-150 Cells.
Li S; Qu Y; Shen XY; Ouyang T; Fu WB; Luo T; Wang HQ
Pharmacology; 2019; 103(5-6):263-272. PubMed ID: 30783055
[TBL] [Abstract][Full Text] [Related]
31. Complex Epigenetic Regulation of Chemotherapy Resistance and Biohlogy in Esophageal Squamous Cell Carcinoma via MicroRNAs.
Lindner K; Eichelmann AK; Matuszcak C; Hussey DJ; Haier J; Hummel R
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29414899
[TBL] [Abstract][Full Text] [Related]
32. Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma.
Liu A; Zhu J; Wu G; Cao L; Tan Z; Zhang S; Jiang L; Wu J; Li M; Song L; Li J
Mol Cancer; 2017 Jun; 16(1):106. PubMed ID: 28633632
[TBL] [Abstract][Full Text] [Related]
33. Overcoming Linsitinib intrinsic resistance through inhibition of nuclear factor-κB signaling in esophageal squamous cell carcinoma.
Wu J; Chen K; Zhang F; Jin J; Zhang N; Li D; Ying L; Chen W; Yu H; Mao W; Su D
Cancer Med; 2017 Jun; 6(6):1353-1361. PubMed ID: 28440057
[TBL] [Abstract][Full Text] [Related]
34. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance and biological role of cancer-derived Type I collagen in lung and esophageal cancers.
Fang S; Dai Y; Mei Y; Yang M; Hu L; Yang H; Guan X; Li J
Thorac Cancer; 2019 Feb; 10(2):277-288. PubMed ID: 30604926
[TBL] [Abstract][Full Text] [Related]
36. Phosphatidylinositol 3-kinase-C2β inhibits cisplatin-mediated apoptosis via the Akt pathway in oesophageal squamous cell carcinoma.
Liu Z; Sun C; Zhang Y; Ji Z; Yang G
J Int Med Res; 2011; 39(4):1319-32. PubMed ID: 21986133
[TBL] [Abstract][Full Text] [Related]
37. Proton pump inhibitors (PPIs) impact on tumour cell survival, metastatic potential and chemotherapy resistance, and affect expression of resistance-relevant miRNAs in esophageal cancer.
Lindner K; Borchardt C; Schöpp M; Bürgers A; Stock C; Hussey DJ; Haier J; Hummel R
J Exp Clin Cancer Res; 2014 Sep; 33(1):73. PubMed ID: 25175076
[TBL] [Abstract][Full Text] [Related]
38. IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma.
Myers AL; Lin L; Nancarrow DJ; Wang Z; Ferrer-Torres D; Thomas DG; Orringer MB; Lin J; Reddy RM; Beer DG; Chang AC
Oncotarget; 2015 Sep; 6(28):25897-916. PubMed ID: 26317790
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy.
Tsurutani J; West KA; Sayyah J; Gills JJ; Dennis PA
Cancer Res; 2005 Sep; 65(18):8423-32. PubMed ID: 16166321
[TBL] [Abstract][Full Text] [Related]
40. Stromal extracellular matrix reduces chemotherapy-induced apoptosis in colon cancer cell lines.
Kouniavsky G; Khaikin M; Zvibel I; Zippel D; Brill S; Halpern Z; Papa M
Clin Exp Metastasis; 2002; 19(1):55-60. PubMed ID: 11918083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]